Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-23 4:17 PM View:  | Lianbio (LIAN) | 29-Mar-23 | Grant | 325,901 | -- | -- | 100% 0 to 325.9K | |
| 10-Feb-21 5:58 PM View: | Turning Point Therapeutics,... (TPTX) | 08-Feb-21 | Grant | 4,617 | -- | -- | 171% 2.7K to 7.32K | |
| 02-Feb-21 9:47 PM View: | Turning Point Therapeutics,... (TPTX) | 02-Feb-21 | Option Exercise | 14,298 | $54.03 | $772,521.00 | 529% 2.7K to 17.0K | |
| 02-Feb-21 9:47 PM View: | Turning Point Therapeutics,... (TPTX) | 02-Feb-21 | Market Option Sale (Planned) | 14,298 | $130.15 | $1,860,810.00 | (84%) 17.0K to 2.7K | (3%) |
| 02-Feb-21 9:47 PM View: | Turning Point Therapeutics,... (TPTX) | 01-Feb-21 | Option Exercise | 15,702 | $54.03 | $848,379.00 | 581% 2.7K to 18.41K | |
| 02-Feb-21 9:47 PM View: | Turning Point Therapeutics,... (TPTX) | 01-Feb-21 | Market Option Sale (Planned) | 15,702 | $123.62 | $1,941,100.00 | (85%) 18.41K to 2.7K | (9%) |
| 11-Sep-19 4:16 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Sep-19 | Market Purchase | 2,222 | $45.00 | $99,990.00 | 100% 0 to 2.22K | 199% |